CHROMATINLENS

What this means for you

Not registered yet, but its 03 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79447332

Mark type

Word mark

Filed

03 Dec 2025

Attorney of record

Alexandra MacKay

Goods and services

• Class 001 — Chemicals: Synthetic promoters for scientific and industrial purposes; gene expression vectors for scientific and industrial purposes; synthetic enhancers in gene expression cassettes for scientific and industrial purposes; chemical and enzyme preparations for scientific and industrial purposes; regulatory proteins for scientific and industrial use; diagnostic biomarker reagents for scientific and industrial purposes; chemical reagents for use in genetic research; assays and reagents for use in genetic research; nucleic acid sequences and chemical reagents for scientific and industrial purposes; synthetic promoters for crop growth; growth promoters in the nature of human-created DNA sequences for use in industry; genetic switches and promoters for scientific and industrial purposes; DNA sequences and RNA sequences for scientific and industrial purposes; genetic carriers, namely cells and viruses for scientific and industrial purposes; transgenes for scientific and industrial purposes; genetic reagents for scientific and industrial purposes; target antigens for scientific and industrial purposes
• Class 005 — Pharmaceuticals: Synthetic promoters for medical and clinical purposes; gene expression vectors for medical and clinical purposes; synthetic enhancers in gene expression cassettes for medical or clinical use; regulatory proteins for medical use; genetic switches and promoters for medical and clinical purposes; DNA sequences and RNA sequences for medical purposes; genetic carriers, namely cells and viruses for medical and clinical purposes; chemical and enzyme preparations for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; nucleic acid sequences and chemical reagents for medical and veterinary purposes; RNA therapeutics namely, RNA-based pharmaceutical preparations for gene therapy for the treatment of genetic disorders, cancer, and rare diseases; pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment and prevention of genetic disorders, cancer and rare diseases; transgenes for medical purposes; gene therapy pharmaceuticals for the treatment of genetic disorders, cancer and rare diseases; biotechnological preparations for medical use; biological compounds for use in the targeted pharmaceutical therapies for the treatment of genetic disorders, cancer and rare diseases; genetic reagents for medical and clinical purposes; biological preparations for use in cells and cell cultures for medical and clinical use; target antigens for medical use
• Class 009 — Scientific and electric apparatus: Downloadable databases in the field of genomics, functional genomics, epigenetics, gene regulation and gene expression; data sets, recorded or downloadable in the field of genomics, functional genomics, epigenetics, gene regulation and gene expression; epigenetic data-sets downloadable data-sets in the field of epigenetics; downloadable data sets in the fields of multiomics, gene expression and biopharmaceuticals; data processing systems comprised of downloadable software for analysing genomic, epigenetic and gene expression data and downloadable databases containing genomic and multi-omics information; downloadable computer software for analysing genomic, epigenetic, transcriptomic and multi-omics data and for designing synthetic promoters and gene expression systems for use in the fields of epigenetics, gene expression, gene regulation, genomics, genetic markers, functional genomics, biomarkers, bioinformatics, bio-processing, biologics, genomic signals, gene therapies, genetic sequencing, promoters, synthetic promoters, gene expression cassettes, vectors, recombinant protein production, cell engineering, biopharmaceuticals, molecular genetics, DNA assembly, DNA synthesis, DNA sequencing, RNA sequencing, transgenes, predicting protein expression, synthetic biology, engineering biology, protein engineering, cells, biochemical reagents, recombinant protein production, viral vector engineering, modulating therapeutics, and predicting protein expression; downloadable computer software for the structural and functional analysis of genomes; downloadable computer software for scientific analysis of genetic sequences; downloadable computer software in the nature of algorithms used for medical research and scientific discovery; downloadable computer software for creating, analyzing and running algorithms; downloadable bioinformatics software for analysing genomic sequences, identifying regulatory elements and predicting gene expression; downloadable software for data processing; downloadable software for data mining; downloadable artificial intelligence and machine learning software for analysing genomic datasets, identifying gene regulatory elements and predicting gene expression patterns; downloadable computer software platforms for analysing functional genomics data and designing synthetic promoters and gene expression vectors; laboratory devices for analysing genome information; laboratory instruments in the nature of nucleic acid sequencers for scientific purposes; signal processing apparatus for processing genomic, transcriptomic and multi-omics data
• Class 042 — Scientific and technological services: Design and development of novel synthetic promoters in the field of genetics; design, development and analysis of epigenetic data systems; genetic engineering services in the nature of design and optimisation of synthetic promoters, enhancers and gene expression systems for scientific research purposes; genetic sequencing and genotyping services for scientific research purposes; genetic sequence optimisation services for scientific research purposes; DNA and RNA sequencing services for scientific research purposes; Polymerase Chain Reaction [PCR] testing services for scientific research purposes; gene regulation control services for scientific research purposes; genome amplification for scientific research purposes; gene silencing services for scientific research purposes; structural and functional analysis of genomes for scientific research purposes; analysis and profiling of gene expression for scientific research purposes; gene regulatory network analysis for scientific research purposes; genetic mapping and testing for scientific purposes; genetic engineering services in the field of plants; cell engineering services, namely cell suppression, cell activation, and cell programming and reprogramming for scientific research purposes; culturing of cells for scientific or medical research purposes; synthetic biology services in the nature of biological research and in the nature of design and development of synthetic promoters, gene expression vectors and genetic regulatory elements for scientific research purposes; metabolic engineering services for scientific research purposes; scientific research services in the field of biologics production; biological research laboratory services; research and development services in the fields of epigenetics, gene expression, gene regulation, genomics, genetic markers, functional genomics, biomarkers, bioinformatics, bio-processing, biologics, genomic signals, gene therapies, genetic sequencing, promoters, synthetic promoters, gene expression cassettes, vectors, recombinant protein production, cell engineering, biopharmaceuticals, molecular genetics, DNA assembly, DNA synthesis, DNA sequencing, RNA sequencing, transgenes, predicting protein expression, synthetic biology, engineering biology, protein engineering, cells, biochemical reagents, recombinant protein production, viral vector engineering, modulating therapeutics, and predicting protein expression; research and development services in the field of genetic dark matter; research and development services in the field of gene expression systems; contract research services in the nature of design, development and optimisation of promoters and gene expression vectors in the field of promoters and gene expression vectors; computer aided analysis services in the field of epigenetics; design, development and maintenance of database systems; hosting of online databases featuring scientific data in the field of multiomics; scientific research conducted using databases; data mining services; analysis of technical data; preparation of technical reports concerning genomics, functional genomics, gene expression, gene regulation and synthetic promoter design; design and development of lab information management systems; design of data processing systems; design and development of computer platforms; design, development and maintenance of software in the fields of epigenetics, gene expression, gene regulation, genomics, genetic markers, functional genomics, biomarkers, bioinformatics, bio-processing, biologics, genomic signals, gene therapies, genetic sequencing, promoters, synthetic promoters, gene expression cassettes, vectors, recombinant protein production, cell engineering, biopharmaceuticals, molecular genetics, DNA assembly, DNA synthesis, DNA sequencing, RNA sequencing, transgenes, predicting protein expression, synthetic biology, engineering biology, protein engineering, cells, biochemical reagents, recombinant protein production, viral vector engineering, modulating therapeutics, and predicting protein expression; providing temporary use of online, non-downloadable software for analysing genomic, epigenetic and multi-omics data, identifying gene regulatory elements, predicting gene expression patterns and designing synthetic promoters and gene expression systems in the fields of epigenetics, gene expression, gene regulation, genomics, genetic markers, functional genomics, biomarkers, bioinformatics, bio-processing, biologics, genomic signals, gene therapies, genetic sequencing, promoters, synthetic promoters, gene expression cassettes, vectors, recombinant protein production, cell engineering, biopharmaceuticals, molecular genetics, DNA assembly, DNA synthesis, DNA sequencing, RNA sequencing, transgenes, predicting protein expression, synthetic biology, engineering biology, protein engineering, cells, biochemical reagents, recombinant protein production, viral vector engineering, modulating therapeutics, and predicting protein expression; design, development and maintenance of machine learning software for use in bioinformatics, genetic sequencing, predicting protein expression, cell suppression and analysis of cell behaviours; design, development and maintenance of software algorithms for in the fields of epigenetics, medical research and scientific discovery; development and testing of computing methods, algorithms and software; consultancy, information and advisory services relating to all of the aforesaid services

Owner

• Chromatin Bioscience Ltd, GB

Prosecution history

• 25 Oct 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 25 Oct 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 25 Oct 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 11 Jun 2026 — REFUSAL PROCESSED BY IB
• 25 May 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 25 May 2026 — REFUSAL PROCESSED BY MPU
• 14 Apr 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 13 Apr 2026 — NON-FINAL ACTION WRITTEN
• 06 Apr 2026 — ASSIGNED TO EXAMINER
• 03 Apr 2026 — APPLICATION FILING RECEIPT MAILED
• 03 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 02 Apr 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB